fosinopril has been researched along with aldosterone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duchin, KL; Frantz, M; Manning, J; Tu, JI; Waclawski, AP; Willard, DA | 1 |
| Davis, J; Duchin, KL; Fakhry, I; Gehr, TW; Grasela, DM; Sica, DA | 1 |
| Ardeleani, G; Bragato, R; Morganti, A; Pulzzani, E; Sala, C; Zanchetti, A | 1 |
| Cervenka, J; Dineen, M; O'Connor, DT; Sullivan, PA | 2 |
| Aberg, G; Andersson, RG; Jacobsson, LS; Karlberg, BE; Olsson, AG; Persson, K | 1 |
| Andersson, RG; Jacobsson, L; Persson, K | 1 |
| Ford, NF; Fulmor, IE; Hui, KK; Natarajan, C; Smith, RA | 1 |
| Azizi, M; Guyene, TT; Mangold, B; Massien, C; Ménard, J; Vesterqvist, O | 1 |
| Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
| Bitzur, R; Grossman, E; Harats, D; Levkovitz, H; Shaish, A; Sharabi, Y; Sherer, Y | 1 |
| Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
| Berezin, AE | 1 |
| Kazory, A; Weiner, ID | 1 |
5 trial(s) available for fosinopril and aldosterone
| Article | Year |
|---|---|
Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects.
Topics: Adolescent; Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Evaluation; Fosinopril; Humans; Male; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Single-Blind Method | 1991 |
Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Exercise; Fosinopril; Hormones; Humans; Hypertension; Male; Middle Aged; Potassium; Proline; Propranolol; Random Allocation; Renin; Rest | 1989 |
Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Administration Schedule; Fosinopril; Hormones; Humans; Hypertension; Middle Aged; Physical Exertion; Potassium; Proline; Renin; Rest | 1988 |
Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Fosinopril; Humans; Male; Neprilysin; Pyridines; Reference Values; Renin; Thiazepines; Time Factors | 1999 |
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
9 other study(ies) available for fosinopril and aldosterone
| Article | Year |
|---|---|
Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Female; Fosinopril; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Proline; Renin | 1991 |
Reciprocal changes in atrial natriuretic factor and aldosterone during angiotensin converting enzyme inhibition in man.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Dose-Response Relationship, Drug; Fosinopril; Heart Rate; Humans; Male; Potassium; Proline; Reference Values; Renin | 1989 |
Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs.
Topics: Aldosterone; Animals; Arteriosclerosis; Blood Pressure; Captopril; Diet, Atherogenic; Female; Fosinopril; Hypercholesterolemia; Lipoproteins; Peptidyl-Dipeptidase A; Renin; Swine; Swine, Miniature | 1994 |
Angiotensin converting enzyme inhibitors and atherosclerosis.
Topics: Acetylcholine; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Arteriosclerosis; Captopril; Cholesterol; Diet, Atherogenic; Endothelium, Vascular; Female; Fosinopril; Hypercholesterolemia; Muscle Relaxation; Peptidyl-Dipeptidase A; Renin; Swine; Swine, Miniature | 1994 |
Invasive pharmacodynamics of fosinopril in patients with congestive heart failure.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Chromatography, High Pressure Liquid; Female; Fosinopril; Half-Life; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Wedge Pressure; Renin | 1995 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
The effect of renin-angiotensin axis inhibition on early atherogenesis in LDL-receptor-deficient mice.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Fosinopril; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; Renin-Angiotensin System; Sinus of Valsalva; Triglycerides | 2000 |
[Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure].
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Data Interpretation, Statistical; Echocardiography; Fosinopril; Heart Failure; Humans; Immunoenzyme Techniques; Middle Aged; Natriuretic Peptide, Brain; Radioimmunoassay; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
Primary hyperaldosteronism in a patient with end-stage renal disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Follow-Up Studies; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Renal Dialysis; Renin; Spironolactone | 2007 |